ライフサイエンスコーパス: hypovolemic

1 cts a widespread clinical assumption that in hypovolemic cardiac arrest, the ventricles are collapsed

2 rcine models of ventricular fibrillation and hypovolemic cardiac arrest.

3 asopressors given during resuscitation after hypovolemic cardiac arrest.

4 ntilation and various shock states including hypovolemic, cardiogenic, obstructive, and septic shock.

5 or salt appetite in response to an isotonic hypovolemic challenge.

6 d the hypothesis that patients with POTS are hypovolemic compared with healthy controls and explored

7 e changes are of particular importance under hypovolemic conditions, especially when central venous b

8 were performed randomly in normovolemic and hypovolemic conditions.

9 All patients were hypovolemic (global end-diastolic volume index<680 mL/m)

10 hen intravenously during ischemia induced by hypovolemic hypotension and bilateral common carotid art

11 set of cardiovascular collapse during severe hypovolemic hypotension in spontaneously breathing human

12 nvasive hemodynamic support in patients with hypovolemic hypotension once the blood loss has been con

13 nd limitations of this new approach to treat hypovolemic hypotension.

14 the prevention of ischemic tissue damage and hypovolemic (low blood volume) shock.

15 ontrol (n = 3), control plus L-NAME (n = 5), hypovolemic (n = 4), and hypovolemic plus L-NAME (n = 5)

16 s with pulmonary edema during the study were hypovolemic or euvolemic at the time pulmonary edema dev

17 igh plasma aldosterone levels detected under hypovolemic or hyperkalemic challenge can lead to increa

18 Plasma lactate was lower in hypovolemic patients before (rs=0.38; p=0.05) and after

19 e minimal; however, hypotension can occur in hypovolemic patients.

20 g initial studies with both normovolemic and hypovolemic pigs, sequential increases in inspiratory im

21 lus L-NAME (n = 5), hypovolemic (n = 4), and hypovolemic plus L-NAME (n = 5).

22 Hypovolemic rabbits were bled of 10% of their circulatin

23 ean (p = .009) blood pressures compared with hypovolemic rabbits who received saline placebo.

24 al conditions other than hypoxia, such as in hypovolemic, septic, or cardiogenic shock.

25 The 30-day mortality rate was 18.4%, and hypovolemic shock (odds ratio 4.75; 95% confidence inter

26 tcomes Consortium in patients with traumatic hypovolemic shock (shock) or traumatic brain injury (TBI

27 injured patients, age 15 years or more with hypovolemic shock [systolic blood pressure (SBP) </= 70

28 ude that L-NAME may blunt hypotension during hypovolemic shock by inhibiting nitric oxide synthase an

29 Hypovolemic shock causes a whole body ischemia/reperfusi

30 c activity and mean arterial pressure during hypovolemic shock compared with control rabbits.

31 olecular research applies more to protracted hypovolemic shock followed by the systemic inflammatory

32 IL-4 exacerbation of histamine-induced hypovolemic shock in mice was dependent on VE expression

33 Hypotension during hypovolemic shock may be attributable, in part, to the f

34 Hypovolemic shock of marked severity and duration may pr

35 with shock or TBI occur within 24 hours from hypovolemic shock or TBI.

36 during a prearrest control period and during hypovolemic shock produced by rapid hemorrhage of 35% of

37 d vs crystalloid solutions for management of hypovolemic shock remains unclear.

38 During hypovolemic shock there was a decrease in log low-freque

39 and left ventricular diameter compared with hypovolemic shock values by 34 +/- 2.5% and 20 +/- 2.5%,

40 Hypovolemic shock was present in 21.8% of patients, and

41 l stratified by case mix (sepsis, trauma, or hypovolemic shock without sepsis or trauma).

42 ied Model for End-Stage Liver Disease score, hypovolemic shock, and bacterial infection at inclusion

43 ortality resulting from intestinal bleeding, hypovolemic shock, and sepsis, even at a very low DSS co

44 cy, Model for End-Stage Liver Disease score, hypovolemic shock, hepatocellular carcinoma, and active

45 Hypovolemic shock, high-density lipoprotein, platelet co

46 randomized, double-blind trial of traumatic hypovolemic shock, HSD (250 mL) versus lactated Ringer's

47 Among patients with severe TBI not in hypovolemic shock, initial resuscitation with either hyp

48 a variety of serious complications including hypovolemic shock, thrombocytopenia, and bleeding.

49 eased vascular permeability that may lead to hypovolemic shock.

50 k syndrome is a very rare cause of recurrent hypovolemic shock.

51 e of 8 or less who did not meet criteria for hypovolemic shock.

52 ew therapeutic approach for the treatment of hypovolemic shock.

53 ension and acute renal failure, secondary to hypovolemic shock.

54 uces a potent vasoconstrictive effect during hypovolemic states.

55 ntegrated baroreflex response to progressive hypovolemic stimuli.

56 oxone would augment tolerance to hypotensive hypovolemic stress (lower body negative pressure [LBNP])